SOMNUS MEDICAL TECHNOLOGIES INC risk profile
42 Elevated one input has moved against it
Measured 21 October 2026 from SOMN's filed statements. Recomputed nightly.
42 (Elevated), driven by Cash conversion at 64, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 20 | Normal | Stable | One-year price volatility — 14.2% |
| Operating pressure | 51 | Elevated | Worsening | Costs outgrowing revenue — +2.7 percentage points |
| Cash conversion | 64 | Stretched | Worsening | Capital spending against operating cash — 1.30x |
| Leverage and coverage | 37 | Normal | Stable | Current ratio — 0.65x |
| Competitive position | 38 | Normal | Stable | Revenue-growth gap against peers — -2.2 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Utilities companies with a risk reading
NextEra Energy Inc 52Iberdrola S.A. 36Southern Company 46Enel SpA 45Constellation Energy Corporation 43Duke Energy Corp 47National Grid Plc 48National Grid PLC 49American Electric Power Company Inc 43Engie S.A. 60Dominion Energy Inc 44Sempra 56
Financials, valuation and price history for SOMNUS MEDICAL TECHNOLOGIES INC